Changing Consumer Indulgence Habits The GLP-1 revolution has been associated with a general reduction in food consumption, leading some to predict a downturn for the food industry
About 56% of participants had type 2 diabetes, and about 73% had obesity
The main reason some people stop taking them
Nausea in the mornings, some digestive upset after larger meals
The gradual dose escalation schedule specifically aims to minimise side effects whilst building towards the therapeutic dose
Summer and I discuss: What food noise is, and how it goes far beyond hunger or cravings Her personal experience with obesity, weight loss, and taking GLP-1s Overlap between food noise, chronic dieting, and disordered eating patterns Who should (and shouldn't) be on these drugs Risks and benefits of GLP-1 use in different populations The importance of ongoing professional support while using GLP-1 meds Why inappropriate GLP-1 use cases shouldnt overshadow people genuinely benefiting from these medications How weight stigma and judgment can make conversations around GLP-1 use even more difficult Why compassion, individualized care, and ongoing professional support matter I hope this episode helps you better understand GLP-1 medications and the experiences of those who use them
